BridgeBio Oncology Therapeutics, Inc. Common Stock BBOT
$6.75
-23.76%
at last close
Recent SEC Filings
| Form | Description | Filed | Document |
|---|---|---|---|
| 8-K | 8-K | 2026-09-08 | View → |
| S-3 | S-3 | 2026-09-01 | View → |
| 10-Q | 10-Q | 2026-08-11 | View → |
| 8-K | 8-K | 2026-08-11 | View → |
| 4 | 4 | 2026-07-06 | View → |
| 4 | 4 | 2026-07-06 | View → |
| 4 | 4 | 2026-07-06 | View → |
| 4 | 4 | 2026-07-06 | View → |
| 4 | Insider transaction | 2026-07-06 | View → |
| 8-K | 8-K | 2026-06-22 | View → |
| 4 | 4 | 2026-06-18 | View → |
| 4 | 4 | 2026-06-18 | View → |
| 4 | 4 | 2026-06-18 | View → |
| 4 | 4 | 2026-06-18 | View → |
| 4 | 4 | 2026-06-18 | View → |
| 4 | 4 | 2026-06-18 | View → |
| 4 | 4 | 2026-06-18 | View → |
| 10-Q | 10-Q | 2026-05-12 | View → |
| 8-K | 8-K | 2026-05-12 | View → |
| 4 | 4 | 2026-05-12 | View → |
| 4 | 4 | 2026-05-12 | View → |
| 4 | 4 | 2026-05-05 | View → |
| 4 | 4 | 2026-05-05 | View → |
| 4 | 4 | 2026-05-05 | View → |
| 8-K | 8-K | 2026-04-29 | View → |
| DEF 14A | DEF 14A | 2026-04-28 | View → |
| 8-K | 8-K | 2026-04-23 | View → |
| 4 | 4 | 2026-03-26 | View → |
| 8-K | 8-K | 2026-03-26 | View → |
| 4 | 4 | 2026-03-12 | View → |
| 4 | 4 | 2026-03-12 | View → |
| 4 | 4 | 2026-03-12 | View → |
| 10-K | 10-K | 2026-03-05 | View → |
| 8-K | 8-K | 2026-03-05 | View → |
| 8-K | 8-K | 2026-01-07 | View → |
| 4 | 4 | 2026-01-05 | View → |
| 4 | 4 | 2025-12-12 | View → |
| 10-Q | 10-Q | 2025-11-12 | View → |
| 8-K | 8-K | 2025-11-12 | View → |
| 4 | 4 | 2025-10-16 | View → |
Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.
Key Stats
- Last Close
- $6.75
- Market Cap
- $710.34 million
- 52-Week Range
- $6.29 – $14.87
- Average Volume
- 301K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.